Skip to Main Content

Paper Details

Clinical and metabolomic characterization of Brivanib-Induced hypertension in metastatic colorectal cancer.
Cancer Med
3
2023
Brivanib, CRC, advanced colorectal cancer, brivanib, cetuximabthe, hypertension, metastatic CRC, metastatic colorectal cancer, patient, patients, plasma, pre-eclampsia, tumor, tyrosine, tyrosine kinase, vasoconstriction
Author NameAffiliation
Hans J VogelUniversity of Calgary
Lillian L SiuPrincess Margaret Cancer Centre
Oliver F BatheCumming School of Medicine, Arnie Charbonneau Cancer Institute, University of Calgary
Oliver F BatheCumming School of Medicine, University of Calgary
Oliver F BatheCumming School of Medicine, Arnie Charbonneau Cancer Institute, University of Calgary
Oliver F BatheCumming School of Medicine, University of Calgary
  • 1 - 6

Datasets

Release 1.2